[en] A 64 year old patient with heart failure due to primary cardiac amyloidosis is described. This case offers the opportunity to review the literature dealing with the cardiac involvement associated with this disorder and the differential diagnosis of restrictive heart disease.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
FALQUE, Bertrand ; Centre Hospitalier Universitaire de Liège - CHU > Service de cardiologie
DAVIN, Laurent ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Cardiologie interventionnelle
MELON, Pierre ; Centre Hospitalier Universitaire de Liège - CHU > Cardiologie
ROBINET, Sébastien ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Rythmologie & Pacemaker
BRUYERE, Pierre-Julien ; Centre Hospitalier Universitaire de Liège - CHU > Département de Physique Médicale > Service médical de radiodiagnostic
Pierard, Luc ; Université de Liège - ULiège > Département des sciences cliniques > Cardiologie - Pathologie spéciale et réhabilitation
Language :
French
Title :
Le cas clinique du mois. Amyloidose cardiaque, a propos d'un cas atypique.
Alternative titles :
[en] Cardiac amyloidosis, about an atypical case
Publication date :
2013
Journal title :
Revue Médicale de Liège
ISSN :
0370-629X
eISSN :
2566-1566
Publisher :
Université de Liège. Revue Médicale de Liège, Liège, Belgium
Al Suwaidi J, Velianou JL, Gertz MA, et al. - Systemic amyloidosis presenting with angina pectoris. Ann Intern Med, 1999, 131, 838.
Mathew Y Olson LJ, Gertz MA, Hayes DL. - Symptomatic conduction system disease in cardiac amyloidosis. Am J Cardiol, 1997, 80, 1491.
Falk RH, Rubinow A, Cohen AS. - Cardiac arrythmias in systemic amyloidosis: correlation with echocardiographic abnormalities. J Am Coll Cardiol, 1984, 3, 107-113.
Navarro JF, Rivera M, Ortuno J. - Cardiac tamponade as presentation of systemic amyloidosis. Int J Cardiol, 1992, 36, 107.
Falk RH, Plehn JF, Deering T, et al. - Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis. Am J Cardiol, 1987, 59, 418-422.
Van Geluwe F, Dymarkowski S, Crevits I, et al. - Amyloidosis of the heart and respiratory system. Eur Radiol, 2006, 16, 2358-2365. Epub 2006 May 16.
Hansen MW, Merchant N. - MRI of hypertrophic cardiomyopathy: part 2. Differential diagnosis, risk stratification, and posttreatment MRI appearances. AJR Am J Roentgenol, 2007, 189, 1344-1352.
Van Den Driesen RI, Slaughter RE, Strugnell WE. - MR findings in cardiac amyloidosis. AJR Am J Roentgenol 2006, 186, 1682-1685.
Maceira AM, Joshi J, Prasad SK, et al. - Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation, 2005, 111, 186-193.
Ruberg FL, Appelbaum E, Davidoff R, et al. - Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis. Am J Cardiol 2009, 103, 544-549.
Perugini E, Rapezzi C, Piva T, et al. - Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. Heart, 2006, 3, 343-349.
Rahman JE, Helou EF, Gelzer-Bell R, et al. - Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. J Am Coll Cardiol 2004, 43, 410-415.
Cueto-Garcia L, Reeder GS, Kyle RA, et al. - Echocar-diographic findings in systemic amiloidosis: spectrum of cardiac involvement and relation to survival. J Am Coll Cardiol 1985, 5, 737-743.
Martin Y, Porras M, Vi Vario M, Delfosse Y P. Materne, et al. - Hoffer Le cas clinique du mois: Amyloïdose cardiaque de type AL: àpropos d'un cas. Rev Med Liège, 2009, 64, 434-439.
Klein AL, Hatle LK, Taliercio CP, et al. - Serial Doppler echocardiographic follow-up of left ventricular diastolic function in cardiac amyloidosis. J Am Coll Cardiol 1990, 16, 1135-1141.
Falk RH, Plehn JF, Deering T, et al. - Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis. Am J Cardiol, 1987, 59, 418-422.
Sallach JA, Klein AL. - Tissue Doppler imaging in the evaluation of patients with cardiac amyloidosis. Curr Opin Cardiol, 2004, 19, 464-471.
Austin BA, Duffy B, Tan C, et al. - Comparison of functional status, electrocardiographic, and echocardiographic parameters to mortality in endomyocardial-biopsy proven cardiac amyloidosis. Am J Cardiol, 2009, 103, 1429-1433.
Eshaghian S, Kaul S, Shah PK. - Cardiac amyloidosis: new insights into diagnosis and management. Rev Cardiovasc Med, 2007, 8, 189-199.
Arbustini E, Merlini G, Gavazzi A, et al. - Cardiac immunocyte-derived (AL) amyloidosis: an endomyocardial biopsy study in 11 patients. Am Heart J, 1995, 130, 528.
Kyle RA, Greipp RR. - Amyloidosis (AL). Clinicale and laboratory features in 229 cases. Mavo Clin Proc, 1983, 58, 665-683.
Rubinow A, Skinner M, Cohen AS. - Digoxin sensitivity in amyloid cardiomyopathy. Circulation, 1981, 63, 1285.
Gertz MA, Skinner M, Connors LH, et al. - Selective binding of nifedipine to amyloid fibrils. Am J Cardiol, 1985, 55, 1646.
Feng D, Syed IS, Martinez M, et al. - Intracardiac thrombosis and anticoagulation therapy in cardiac amyloidosis. Circulation, 2009, 119, 2490.
Kyle RA, Gertz MA, Greipp PR, et al. - A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. N Engl J Med, 1997, 336, 1202.
Grogan M, Gertz MA, Kyle RA, Tajik AJ. - Five or more years of survival in patients with primary systemic amyloidosis and biopsy-proven cardiac involvement. Am J Cardiol, 2000, 85, 664.
Kristen AY Dengler TJ, Hegenbart U, et al. - Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death. Heart Rhythm, 2008, 5, 235.
